NCT07537920

Brief Summary

There is currently little data comparing intranasal silicone splinting versus trans-septal quilted suturing in terms of preventing problems following septoplasty. The purpose of this study is to compare the results of intranasal silicone splinting with trans-septal quilted suturing following septoplasty. After septoplasty, this study will give us a better procedure with fewer adverse effects. Based on the outcomes, this can then regularly be used that specific approach in general practice to treat these specific individuals in an effort to lower their morbidity

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
1mo left

Started Mar 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Mar 2026Jun 2026

Study Start

First participant enrolled

March 4, 2026

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 12, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 17, 2026

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 3, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 3, 2026

Expected
Last Updated

April 24, 2026

Status Verified

April 1, 2026

Enrollment Period

2 months

First QC Date

April 12, 2026

Last Update Submit

April 21, 2026

Conditions

Keywords

DNSseptoplastyquilting

Outcome Measures

Primary Outcomes (2)

  • Mean post-operative pain

    The visual analogue sacle will measure it during the first week, with 0 denoting no discomfort and 10 denoting the worst pain

    48 hours

  • Rate of septal hematoma

    A accumulation of blood between the cartilage and the bony nasal septum is known as a nasal septal hematoma, and it was considered positive if blood was seen when the needle was aspirated

    4 weeks

Study Arms (2)

trans-septal quilting suturing

EXPERIMENTAL
Procedure: trans-septal quilting suturing

intranasal silicone splinting

PLACEBO COMPARATOR
Procedure: intranasal silicone splinting

Interventions

The dead space in group A will be closed using a 3-0 vicryl and a curved cutting needle. The suture was first positioned at the posterior end of the septum under endoscopic view, and a knot will be tied at the distal end of the suture material. After that, the process continued continuously from inferior to superior side-to-side in a zigzag pattern until the caudal end of the septum was reached. The suture will then be tied on itself, usually on the side opposite the first knot

trans-septal quilting suturing

a 2-0 silk mattress suture will be used to secure a 1 mm flat silicone splint that has been covered with fucidin ointment intranasally and bilaterally around the septum at the caudal end. Every patient will be monitored for a week, during which time any post-operative pain and any septal hematomas as defined by the procedure will be recorded. Following surgery, synachiae will be evaluated four weeks later

intranasal silicone splinting

Eligibility Criteria

Age10 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • All patients between the ages of 10 and 40 who are having septoplasty for a symptomatic nasal septum deviation identified by anterior rhinoscopy;

You may not qualify if:

  • Patients who have had nasal surgery in the past.
  • Individuals who suffer from bleeding disorders (INR \>1.2).
  • Individuals with co-occurring disorders such as hypertension and diabetes mellitus (based on medical records and history).
  • Individuals with chronic liver disease, as determined by history and s/bilirubin levels greater than 1.0 mg/dl

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sheikh Zayed Hospital

Lahore, Punjab Province, 60000, Pakistan

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

April 12, 2026

First Posted

April 17, 2026

Study Start

March 4, 2026

Primary Completion

May 3, 2026

Study Completion (Estimated)

June 3, 2026

Last Updated

April 24, 2026

Record last verified: 2026-04

Locations